Search clinical trials for: Short acting beta agonist (SABA) (rescue medication)
Total 3083 results
-
Indiana UniversityOffice of Naval Research (ONR)CompletedResting Energy Expenditure | Brown Adipose Tissue | ThermogenesisUnited States
-
Korea University Anam HospitalActive, not recruitingHypertensionKorea, Republic of
-
Astellas Pharma China, Inc.CompletedPharmacokinetics of Mirabegron | Food Effect | Healthy Chinese SubjectsChina
-
Swiss Group for Clinical Cancer ResearchCompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myeloproliferative NeoplasmSwitzerland
-
CHU de Quebec-Universite LavalCompletedOveractive Bladder | Urinary Incontinence
-
Mercy ResearchForest LaboratoriesCompletedHypertensionUnited States
-
Astellas Pharma IncCompleted
-
Mylan Bertek PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Israel
-
Theodore R. Brown, MD MPHAstellas Pharma IncCompletedMultiple SclerosisUnited States
-
Baylor College of MedicineCompletedUreteral Obstruction | Flank PainUnited States
-
Assistance Publique - Hôpitaux de ParisAssociation Française contre les Myopathies (AFM), ParisCompletedHeart Failure | Duchenne Muscular Dystrophy | CardiomyopathyFrance
-
University of California, San DiegoForest LaboratoriesCompletedHypertension | Pre-hypertensionUnited States
-
Buddhist Tzu Chi General HospitalCompletedUrinary Incontinence | Overactive Bladder Syndrome
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedHealthy Volunteer | Pharmacokinetics of YM178Taiwan
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
National Taiwan University HospitalMinistry of Science and Technology, TaiwanUnknownGastroesophageal Reflux DiseaseTaiwan
-
Jagiellonian UniversityUniversity Hospital in KrakowNot yet recruiting
-
Philip KernNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Philadelphia Urosurgical AssociatesAstellas Pharma Global Development, Inc.TerminatedCystitis, InterstitialUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States, Canada
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States, Hungary, Canada, Spain, Finland, Slovakia, Czechia, Sweden, Germany, Denmark, Norway
-
Massachusetts General HospitalForest LaboratoriesCompletedMicrovascular AnginaUnited States
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Canada
-
Astellas Pharma IncCompletedRenal ImpairmentUnited States
-
Roswell Park Cancer InstituteRecruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell MyelomaUnited States
-
Astellas Pharma IncCompleted
-
Otto MuzikUnknownBrown FatUnited States
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM178Japan
-
AstraZenecaCompleted
-
ALK-Abelló A/SCompletedAllergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
-
AstraZenecaRTI Health SolutionsCompletedPulmonary Disease, Chronic ObstructiveDenmark, Germany, United Kingdom
-
Asan Medical CenterUnknownEnd Stage Liver Disease | Acute Kidney InjuryKorea, Republic of
-
Astellas Scientific & Medical Affairs, Inc.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Canada
-
Oregon Health and Science UniversityActive, not recruitingObesity | Cardiovascular Risk Factor | Circadian DysregulationUnited States
-
University of California, San DiegoRecruiting
-
Ain Shams UniversityRecruiting
-
National Taiwan University HospitalCompletedRecurrence of Overactive Bladder SyndromeTaiwan
-
Astellas Pharma IncCompleted
-
University of ArizonaUniversity of DelawareRecruitingCardiovascular Diseases | Smoking Cessation | Sleep | HIVUnited States
-
Daniel Burdick, MDAstellas Pharma US, Inc.Completed
-
HealthPartners InstituteCompletedOveractive Bladder | Parkinson Disease | Impaired CognitionUnited States
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
Icahn School of Medicine at Mount SinaiForest LaboratoriesCompletedHypertension | Left Ventricular Diastolic DysfunctionUnited States
-
Giulio StefaniniAgenzia Italiana del FarmacoActive, not recruitingLymphoma, Large B-Cell, Diffuse | Breast Cancer | Chemotherapy Effect | Cardiotoxicity | Left Ventricular DysfunctionItaly
-
Forest LaboratoriesCompleted
-
The AlfredUnknown
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan